Journey Medical Corporation
NASDAQ:DERM
3.73 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 27.439 | 32.003 | 49.081 | 8.246 | 4.801 | 104.976 | 295.923 | 41.793 | 107.242 | 55.358 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 208.064 | 255.07 | 210.149 | 107.451 | 41.793 |
Cash and Short Term Investments
| 27.439 | 32.003 | 49.081 | 8.246 | 4.801 | 313.04 | 550.993 | 251.942 | 214.693 | 97.151 |
Net Receivables
| 15.222 | 28.208 | 23.112 | 23.928 | 18.955 | 5.724 | 0.052 | 21.4 | 0 | 7.3 |
Inventory
| 10.206 | 14.159 | 9.862 | 1.404 | 0.857 | 8.37 | 0 | 0 | 0 | 0 |
Other Current Assets
| 3.588 | 3.309 | 4.876 | 1.664 | 0.655 | 8.275 | 5.569 | 10.649 | 2.54 | 1.012 |
Total Current Assets
| 56.455 | 77.679 | 84.493 | 35.242 | 25.268 | 335.409 | 556.614 | 283.991 | 217.233 | 105.463 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 0.101 | 0.189 | 0.089 | 0.175 | 0.089 | 1.18 | 1.433 | 1.127 | 0.386 | 0.192 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0.771 | 0.771 | 0.771 | 0.771 | 0.771 |
Intangible Assets
| 20.287 | 27.197 | 12.552 | 15.029 | 7.377 | 0.952 | 1.126 | 1.126 | 1.126 | 3.52 |
Goodwill and Intangible Assets
| 20.287 | 27.197 | 12.552 | 15.029 | 7.377 | 1.723 | 1.897 | 1.897 | 1.897 | 4.291 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 2.962 | 0 | 24.551 | 1.019 | 66.483 |
Tax Assets
| 0 | 0 | 0 | 1.454 | 1.119 | 0 | 0.194 | 0.194 | 0.194 | 0.816 |
Other Non-Current Assets
| 0.006 | 0.095 | 0.15 | 0.006 | 0.006 | 3.047 | 0.656 | 0.841 | 1.203 | 0.976 |
Total Non-Current Assets
| 20.394 | 27.481 | 12.791 | 16.664 | 8.591 | 8.912 | 4.18 | 28.61 | 4.699 | 72.758 |
Total Assets
| 76.849 | 105.16 | 97.284 | 51.906 | 33.859 | 344.321 | 560.794 | 312.601 | 221.932 | 178.221 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 18.344 | 36.983 | 22.812 | 1.956 | 2.108 | 15.948 | 15.094 | 13.5 | 9.23 | 5.563 |
Short Term Debt
| 3.099 | 3.031 | 5.42 | 0.085 | 0.083 | 0 | 4.625 | 3.022 | 1.072 | 0.635 |
Tax Payables
| 0.053 | 0.035 | 0.008 | 0 | 0 | 3.193 | 4.625 | 3.022 | 1.072 | 0.635 |
Deferred Revenue
| 0 | 4.991 | 23.374 | 21.615 | 0 | 0 | 4.988 | 4.265 | 10 | 10 |
Other Current Liabilities
| 20.372 | 26.783 | 23.366 | 26.02 | 18.706 | 19.415 | 76.026 | 11.183 | 4.522 | -4.943 |
Total Current Liabilities
| 41.868 | 66.832 | 51.606 | 28.061 | 20.897 | 38.556 | 105.358 | 34.992 | 25.896 | 11.89 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 14.631 | 19.934 | 3.627 | 5.317 | 10.21 | 313.789 | 279.389 | 0 | 0 | 1.936 |
Deferred Revenue Non-Current
| 0 | 0 | -0.008 | -0.099 | 0 | 0 | 25.286 | 29.55 | 10 | 10 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.008 | 0.099 | 0 | 0 | 0.194 | 0.194 | 0.194 | 0.816 |
Other Non-Current Liabilities
| 0 | 1.412 | 0 | 8.236 | 0 | 1.015 | 0.918 | 0.495 | 0.367 | 0 |
Total Non-Current Liabilities
| 14.631 | 21.346 | 3.635 | 13.553 | 10.21 | 314.804 | 305.787 | 30.239 | 10.561 | 12.752 |
Total Liabilities
| 56.499 | 88.178 | 55.241 | 41.614 | 31.107 | 353.36 | 411.145 | 65.231 | 36.457 | 24.642 |
Equity: | ||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 178.221 |
Common Stock
| 0.002 | 0.002 | 0.002 | 0.001 | 0.001 | 0.042 | 0.042 | 0.036 | 0.03 | 0.025 |
Retained Earnings
| -72.355 | -68.502 | -38.874 | 5.12 | -0.163 | -745.038 | -553.393 | -250.132 | -161.048 | -82.649 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -0 | 0 | -0 | -1.017 | -0.511 | -0.198 | -0.075 | -0.016 |
Other Total Stockholders Equity
| 92.703 | 85.482 | 80.915 | 5.171 | 2.914 | 736.974 | 703.511 | 497.664 | 346.568 | 57.998 |
Total Shareholders Equity
| 20.35 | 16.982 | 42.043 | 10.292 | 2.752 | -9.039 | 149.649 | 247.37 | 185.475 | 153.579 |
Total Equity
| 20.35 | 16.982 | 42.043 | 10.292 | 2.752 | -9.039 | 149.649 | 247.37 | 185.475 | 153.579 |
Total Liabilities & Shareholders Equity
| 76.849 | 105.16 | 97.284 | 51.906 | 33.859 | 344.321 | 560.794 | 312.601 | 221.932 | 178.221 |